Reduced-Dose Angiography CT Imaging

Overview

  • Study type

    Observational
  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 16-003687
    Sponsor Protocol Number: 16-003687

About this study

3D angiography (3DA) imaging is a valuable method for assessing cardiovascular anatomy prior to and following trans-catheter intervention.  Current 3DA contributes substantially to the overall patient radiation dose for these procedures.  The purpose of this work is to assess the clinical efficacy of reduced radiation dose 3DA.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria:

  • Adult patients scheduled for interventional procedure to treat congenital or structural heart disease
  • Pediatric patients between the ages 13 and 18 scheduled for interventional procedure to treat congenital or structural heart disease
  • Normal kidney renal function as determined by serum creatinine concentration, creatinine clearance, and/or glomerular filtration rate
  • Written informed consent from the patient and/or the patient’s parent/guardian (for patients 13-17 years old) to participate in the study

Exclusion Criteria:

  • Women who are pregnant

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Nathaniel Taggart, M.D.

Contact us for the latest status

Contact information:

Kenneth Fetterly Ph.D.

(507)266-4384

.
CLS-20305358

Mayo Clinic Footer